Howard W. Robin was appointed President and CEO of Nektar Therapeutics on August 8, 2025.
2 reports, 2 independent
Updated Jun 24
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Howard W. Robin was appointed President and CEO of Nektar Therapeutics on August 8, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nektar Therapeutics
American healthcare company
Nothing else this week.
Coverage
Newest first; wire copies grouped- yahoo.com
- PR NewswireNektar Therapeutics Reports Second Quarter 2025 Financial Results SAN FRANCISCO, Aug. 7, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarte